Table: Sawai Pharmaceutical -9-MTH group results
Feb 9 (Reuters)-
Sawai Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2015 Dec 31, 2014 Mar 31, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 92.38 80.19 124.00
(+15.2 pct) (+18.0 pct) (+17.6 pct)
Operating 19.33 17.40 22.00
(+11.1 pct) (+2.4 pct) (+6.3 pct)
Recurring 19.11 17.35 21.70
(+10.1 pct) (+1.3 pct) (+5.2 pct)
Net 14.01 11.71 15.50
(+19.6 pct) (+8.1 pct) (+10.3 pct)
EPS 380.14 yen 318.45 yen 420.71 yen
EPS Diluted 379.87 yen 318.11 yen
Ann Div 105.00 yen 110.00 yen
-Q2 div 55.00 yen 50.00 yen
-Q4 div 55.00 yen 55.00 yen
NOTE - Sawai Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on SAWAI group
See all newsTable: Sawai Group Holdings -Q1 group results (IFRS)
Table: Sawai Group Holdings -2025/26 group results (IFRS)
Brief: Silchester International Cuts Stake In Sawai Group Holdings To 5.82% From 6.83%, Regulatory Filing Shows
Table: Sawai Group Holdings -9-MTH group results (IFRS)
Table: Sawai Group Holdings 6-MTH group results (IFRS)